AddLife AB’s (publ) (“AddLife’s”) rights issue with preferential rights for the Company’s shareholders has been fully subscribed. The subscription period for the rights issue ended 25 April, 2016. The final count shows that 199,360 shares of class A and 4,667,229 shares of class B, corresponding to approximately 98.8 percent of the offered shares, were subscribed for with subscription rights.
The remaining 2,993 shares of class A and 53,836 shares of class B that were not subscribed for with subscription rights have been allocated to those who have applied for subscription of shares without subscription rights in accordance with the principles described in the prospectus. Allotment of shares not subscribed for with subscription rights has only been made to those who have subscribed for shares with subsidiary preferential rights. Interest in the rights issue has been high and as a result of this the rights issue was oversubscribed by 69.6 percent.
Notification regarding allotment of shares which have been subscribed for without subscription rights will be distributed around 28 April, 2016 by settlement note to subscribers or nominees. Subscribed and allotted new shares shall be paid in cash on the settlement day in accordance with the instructions on the settlement note, around 3 May, 2016. Nominee registered shareholders will receive notification regarding allotment of shares in accordance with the respective nominee’s procedures.
Through the rights issue AddLife will receive proceeds amounting to approximately SEK 300 million before deduction of issue costs. As a result of the rights issue, AddLife's share capital will increase by SEK 10,029,188.97 to SEK 50,145,950.97. The number of shares will increase in total by 4,923,418 shares, of which 202,353 new shares are of class A and 4,721,065 new shares are of class B, to a total of 24,617,093 shares, of which 1,011,766 shares are of class A and 23,605,327 shares are of class B.
New shares of class A and class B subscribed for with subscription rights are expected to be registered with the Swedish Companies Registration Office around 29 April, 2016 and trading in the new class B shares on Nasdaq Stockholm is expected to commence on 3 May, 2016. The class B shares subscribed for without subscription rights are expected to start trading on Nasdaq Stockholm on 9 May, 2016.
Handelsbanken Capital Markets acts as financial adviser in connection with the rights issue. Advokatfirman Delphi acts as legal adviser.
For further information, please contact:
Kristina Willgård, CEO, [email protected], +46 70 510 12 23
Martin Almgren, CFO, [email protected], +46 70 228 15 45
The information in this press release shall not constitute an offer to acquire, subscribe for or otherwise trade in shares or other securities in AddLife. No action has been taken and measures will not be taken to permit a public offering in any jurisdictions other than Sweden.
The information in this press release may not be released, published or distributed, directly or indirectly, in or into the United States (including its territories and provinces, every state in the United States and the District of Columbia), Canada, Australia, Japan, Hong Kong, New Zeeland, Switzerland, Singapore, South Africa or any other jurisdiction in which such action is subject to legal restrictions or would require other measures than those required by Swedish law. Actions in violation of these restrictions may constitute a violation of applicable securities laws.
No shares or other securities have or will be registered under the United States Securities Act of 1933 or the securities legislation in any state or other jurisdiction in the United States and may not be offered, subscribed, sold or transferred, directly or indirectly, within the United States.
AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region. AddLife has about 425 employees in some 25 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 1.7 billion. AddLife’s shares are listed on Nasdaq Stockholm.
This information is disclosed in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act and/or the regulations of Nasdaq Stockholm. The information was provided for publication at 08:30 AM on 28 April, 2016.
See www.add.life for further information.